Kathleen Abadie

Sorry, we do not have enough data to show an influence graph for this author.
Learn More
INTRODUCTION Rituximab is an emerging treatment for autoimmune hemolytic anemia. We report the case of a patient with a five-year complete hematologic response to a third course of treatment with rituximab. Cases of response to rituximab re-treatments have been reported, but none to our knowledge that failed multiple prior treatments and achieved as durable(More)
  • 1